-
-
-
-
-
-
-
Leerink Upgrades Replimune Group (REPL) to Outperform
-
-
-
-
-
-
-
Replimune (REPL) files for 25.1M share offering by selling stockholders
-
-
-
-
-
-
-
Replimune (REPL) call put ratio 1 call to 1.2 put amid sharp rally
-
-
-
-
-
-
-
FDA Commissioner Marty Makary is resigning - Politico reporter on X
-
-
-
-
-
-
-
Replimune receives FDA rejection for melanoma treatment RP1
-
-
-
-
-
-
-
Replimune Group, Inc. (REPL) Misses Q3 EPS by 1c
-
-
-
-
-
-
-
Leerink Partners Upgrades Replimune Group (REPL) to Outperform
-
456,282 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

